Location · El Paso, TX
Clinical trials in El Paso, TX
78 recruiting studies have a site in El Paso, and 9 of them accept healthy volunteers.
78 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
C. R. Bard
- Location
- El Paso, TX + 32 other US sites
- Eligibility basics
- Ages 22–70 · Women only
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- El Paso, TX + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- El Paso, TX + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic…
AstraZeneca
- Location
- El Paso, TX + 31 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Hydrus® Microstent New Enrollment Post-Approval Study
Alcon Research
- Location
- El Paso, TX + 12 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- El Paso, TX + 43 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
AstraZeneca
- Location
- El Paso, TX + 3 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2/Phase 3
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Vertex Pharmaceuticals Incorporated
- Location
- El Paso, TX + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
- Location
- El Paso, TX + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Transcend Therapeutics
- Location
- El Paso, TX + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- El Paso, TX + 3 other US sites
- Eligibility basics
- Ages 16+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- El Paso, TX + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kedrion S.p.A.
- Location
- El Paso, TX + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- El Paso, TX + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline
- Location
- El Paso, TX + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- El Paso, TX + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- El Paso, TX + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Viatris Innovation GmbH
- Location
- El Paso, TX + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
ModernaTX, Inc.
- Location
- El Paso, TX + 5 other US sites
- Eligibility basics
- Ages 18–55
- Recruiting
SELUTION4BTK Trial
M.A. Med Alliance S.A.
- Location
- El Paso, TX + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- El Paso, TX + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- El Paso, TX + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- El Paso, TX + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
VenoStent
- Location
- El Paso, TX + 27 other US sites
- Eligibility basics
- Ages 18+